Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF NOVEMBER 23, 2023 SAM #8031
SOURCES SOUGHT

65 -- Adstiladrin (nadofaragene firadenovec-vncg)

Notice Date

11/21/2023 8:29:04 AM
 

Notice Type

Sources Sought
 

NAICS

325412 — Pharmaceutical Preparation Manufacturing
 

Contracting Office

256-NETWORK CONTRACT OFFICE 16 (36C256) RIDGELAND MS 39157 USA
 

ZIP Code

39157
 

Solicitation Number

36C25624Q0221
 

Response Due

11/27/2023 1:00:00 PM
 

Archive Date

12/05/2023
 

Point of Contact

Jeneice Matthews, Contract Specialist, Phone: 713-791-1414 ext. 44002
 

E-Mail Address

jeneice.matthews@va.gov
(jeneice.matthews@va.gov)
 

Awardee

null
 

Description

DISCLAIMER: THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS SYNOPSIS IS NOT A REQUEST FOR QUOTE, PROPOSAL, OR BID. This notice is not a solicitation as defined by FAR 2.101, therefore it shall not be construed as a commitment by the government to enter into a contract, nor does it restrict the government to an acquisition approach. All information contained in this Request for Information (RFI) is preliminary as well as subject to amendment and is in no way binding on the government. Information submitted in response to this notice is voluntary; the government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the government. The government is requesting that restrictive or proprietary markings not be used in response to this notice. If a solicitation is released, it will be synopsized in the Federal Contract Opportunities website or General Services Administration (GSA). It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this RFI. This is a sources sought notice / request for information only. The responses to this posting will be used to establish the procurement strategy for example, set-aside, sole source, unrestricted for a solicitation that VA intends to post in the near future. Title: Adstiladrin (nadofaragene firadenovec-vncg) Purpose: The purpose of this announcement is to identify potential sources which will aid in defining the procurement strategy for example, set-aside, sole source, or unrestricted for a solicitation the VA intends on issuing shortly as follows: The MEDVAMC (Michael E. DeBakey VA Medical Center) located in Houston, Texas has a requirement for Adstiladrin (nadofaragene firadenovec-vncg). Please review the attached document(s) for more details on this requirement. See attached document(s): 36C25624Q0221 Sources Sought Notice
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/f901ed7f90bc467b843ca05f4ea03618/view)
 

Place of Performance

Address: Michael E. DeBakey VA Medical Center 2002 Holcombe Blvd., Houston, TX 77030, USA

Zip Code: 77030

Country: USA
 

Record

SN06892175-F 20231123/231121230052 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |